|
Age, years
|
34.8 ± 3.6
|
32.9 ± 3.6
|
0.029
|
|
History of preeclampsia, n (%)
|
2 (5.4)
|
1 (2.8)
|
0.999
|
|
Onset of preeclampsia, n (%)
|
|
Early onset
|
22 (59.5)
| | |
|
Late onset
|
15 (40.5)
| | |
|
Peak body weight during pregnancy, kg
|
70.4 ± 11.8
|
65.6 ± 7.5
|
0.042 (0.108b)
|
|
Primipara
|
24 (64.9)
|
24 (66.7)
|
0.871
|
|
Twins, n (%)
|
4 (10.8)
|
1 (2.8)
|
0.358
|
|
Gestational week at delivery
|
33.7 ± 3.0
|
37.7 ± 2.0
|
<0.001
|
|
Fetal birth weight, kg
|
1.79 ± 0.58
|
2.93 ± 0.52
|
<0.001
|
|
Waist-to-hip ratio
|
0.92 ± 0.05
|
0.92 ± 0.06
|
0.874
|
|
BMI, m2/kg
|
27.4 ± 5.0
|
25.0 ± 2.8
|
0.015 (0.050b)
|
|
Mean CAVIc
|
6.92 ± 1.69
|
6.53 ± 1.50
|
0.306 (0.032b)
|
|
Hypertensiond, n (%)
|
2 (5.4)
|
0
|
0.494
|
|
Diabetes mellituse, n (%)
|
4 (10.8)
|
0
|
0.115
|
|
SBP, mmHg
|
142.4 ± 12.7
|
111.4 ± 10.5
|
< 0.001
|
|
DBP, mmHg
|
83.9 ± 9.3
|
63.2 ± 7.8
|
< 0.001
|
|
Hemoglobin, mg/dL
|
12.0 ± 2.0
|
11.4 ± 1.8
|
0.164
|
|
Total cholesterol, mg/dL
|
232.6 ± 49.6
|
208.6 ± 46.3
|
0.036
|
|
HDL cholesterol, mg/dL
|
59.9 ± 14.6
|
62.6 ± 13.1
|
0.419
|
|
LDL cholesterol, mg/dL
|
126.2 ± 33.0
|
112.2 ± 33.7
|
0.082 (0.017b)
|
|
Triglyceride, mg/dL
|
255.6 ± 92.5
|
213.6 ± 60.5
|
0.026 (0.061b)
|
|
Creatinine, mg/dL
|
0.693 ± 0.255
|
0.532 ± 0.092
|
0.001 (0.007b)
|
|
AST, IU/L
|
31.0 ± 17.2
|
17.9 ± 7.6
|
< 0.001
|
|
ALT, IU/L
|
27.0 ± 26.9
|
11.4 ± 6.2
|
0.002 (<0.001b)
|
|
Hypertension treatment, n (%)
|
23 (62.2%)
|
0%
|
<0.001
|
|
Treatment regimen, n (%)
|
|
Single drug
|
13 (56.5)
| | |
|
Two drugs
|
8 (34.8)
| | |
|
Three drugs
|
2 (8.7)
| | |
|
Type of antihypertensive drug, n (%)
|
|
CCB
|
23 (100%)
| | |
|
BB
|
2 (8.7%)
| | |
